Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Forte Biosciences (FBRX) Revenue (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Revenue for 5 consecutive years, with -$756000.0 as the latest value for Q1 2020.

  • Quarterly Revenue fell 8500.0% to -$756000.0 in Q1 2020 from the year-ago period, while the trailing twelve-month figure was -$756000.0 through Dec 2020, down 2200.0% year-over-year, with the annual reading at $36000.0 for FY2019, 99.8% down from the prior year.
  • Revenue for Q1 2020 was -$756000.0 at Forte Biosciences, down from $9000.0 in the prior quarter.
  • The five-year high for Revenue was $18.0 million in Q3 2018, with the low at -$756000.0 in Q1 2020.
  • Average Revenue over 5 years is $866941.2, with a median of $9000.0 recorded in 2018.
  • The sharpest move saw Revenue surged 179990.0% in 2018, then crashed 8500.0% in 2020.
  • Over 5 years, Revenue stood at -$522000.0 in 2016, then soared by 101.92% to $10000.0 in 2017, then fell by 10.0% to $9000.0 in 2018, then changed by 0.0% to $9000.0 in 2019, then plummeted by 8500.0% to -$756000.0 in 2020.
  • According to Business Quant data, Revenue over the past three periods came in at -$756000.0, $9000.0, and $9000.0 for Q1 2020, Q4 2019, and Q3 2019 respectively.